Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels.
Colombatto P, Randone A, Civitico G, Monti Gorin G, Dolci L, Medaina N, Calleri G, Oliveri F, Baldi M, Tappero G, Volpes R, David E, Verme G, Smedile A, Bonino F, Brunetto MR. Colombatto P, et al. Among authors: calleri g. J Viral Hepat. 1997;4 Suppl 1:55-60. doi: 10.1111/j.1365-2893.1997.tb00161.x. J Viral Hepat. 1997. PMID: 9097279
Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study.
Saracco G, Sostegni R, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Minoli G, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Rizzetto M. Saracco G, et al. Among authors: calleri g. J Viral Hepat. 2000 Mar;7(2):124-9. doi: 10.1046/j.1365-2893.2000.00198.x. J Viral Hepat. 2000. PMID: 10760042
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
Saracco G, Ciancio A, Olivero A, Smedile A, Roffi L, Croce G, Colletta C, Cariti G, Andreoni M, Biglino A, Calleri G, Maggi G, Tappero GF, Orsi PG, Terreni N, Macor A, Di Napoli A, Rinaldi E, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: calleri g. Hepatology. 2001 Jul;34(1):133-8. doi: 10.1053/jhep.2001.25636. Hepatology. 2001. PMID: 11431744 Clinical Trial.
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
Saracco G, Ciancio A, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Terreni N, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Di Napoli A, Arrigoni A, Rizzetto M; North West Italian Hepatological Group. Saracco G, et al. Among authors: calleri g. Eur J Gastroenterol Hepatol. 2001 Feb;13(2):149-55. doi: 10.1097/00042737-200102000-00010. Eur J Gastroenterol Hepatol. 2001. PMID: 11246614 Clinical Trial.
Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?
Ciancio A, Smedile A, Giordanino C, Colletta C, Croce G, Pozzi M, Cariti G, Macor A, Biglino A, Di Napoli A, Tappero GF, Andreoni M, Manca A, Prandi G, Calleri G, Orsi PG, Ciccone G, Rizzetto M, Saracco G; North West Italian Hepatologic Group. Ciancio A, et al. Among authors: calleri g. Am J Gastroenterol. 2006 Aug;101(8):1811-6. doi: 10.1111/j.1572-0241.2006.00669.x. Epub 2006 Jun 16. Am J Gastroenterol. 2006. PMID: 16780556 Clinical Trial.
A short course of pegylated interferon-alpha in acute HCV hepatitis.
Calleri G, Cariti G, Gaiottino F, De Rosa FG, Bargiacchi O, Audagnotto S, Quaglia S, De Blasi T, Romano P, Traverso A, Leo G, Carbone R, Del Mastro B, Tinelli M, Caramello P, Di Perri G. Calleri G, et al. J Viral Hepat. 2007 Feb;14(2):116-21. doi: 10.1111/j.1365-2893.2006.00802.x. J Viral Hepat. 2007. PMID: 17244251 Clinical Trial.
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
Ciancio A, Picciotto A, Giordanino C, Smedile A, Tabone M, Manca A, Marenco G, Garbagnoli P, Andreoni M, Cariti G, Calleri G, Sartori M, Cusumano S, Grasso A, Rizzi R, Gallo M, Basso M, Anselmo M, Percario G, Ciccone G, Rizzetto M, Saracco G. Ciancio A, et al. Among authors: calleri g. Aliment Pharmacol Ther. 2006 Oct 1;24(7):1079-86. doi: 10.1111/j.1365-2036.2006.03098.x. Aliment Pharmacol Ther. 2006. PMID: 16984502 Free article. Clinical Trial.
83 results